{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:18:09Z","timestamp":1768450689654,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11154-016-9398-4","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T06:22:52Z","timestamp":1480314172000},"page":"521-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The micropapillary\/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution"],"prefix":"10.1007","volume":"17","author":[{"given":"Antonio","family":"Ieni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Licata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Di Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"9398_CR1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C Vecchia La","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136:2187\u201395.","journal-title":"Int J Cancer"},{"key":"9398_CR2","first-page":"83","volume":"40","author":"S Busco","year":"2016","unstructured":"AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, et al. Italian cancer figures--report 2015: the burden of rare cancers in Italy. Epidemiol Prev. 2016;40:83.","journal-title":"Epidemiol Prev"},{"key":"9398_CR3","doi-asserted-by":"crossref","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016.","DOI":"10.1038\/nrendo.2016.110"},{"key":"9398_CR4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321.","journal-title":"Cancer Res"},{"key":"9398_CR5","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/annonc\/mdt301","volume":"24","author":"C Bosetti","year":"2013","unstructured":"Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005\u20132009, and an overview of trends since 1980. Ann Oncol. 2013;24:2657\u201371.","journal-title":"Ann Oncol"},{"key":"9398_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAS.0b013e3181c46677","volume":"34","author":"S Asioli","year":"2010","unstructured":"Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44\u201352.","journal-title":"Am J Surg Pathol"},{"key":"9398_CR7","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.humpath.2011.10.027","volume":"43","author":"LS Lino-Silva","year":"2012","unstructured":"Lino-Silva LS, Dom\u00ednguez-Malag\u00f3n HR, Caro-S\u00e1nchez CH, Salcedo-Hern\u00e1ndez RA. Thyroid gland papillary carcinomas with \u201cmicropapillary pattern,\u201d a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol. 2012;43:1596\u2013600.","journal-title":"Hum Pathol"},{"key":"9398_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.humpath.2012.06.003","volume":"44","author":"S Asioli","year":"2013","unstructured":"Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013;44:320\u20138.","journal-title":"Hum Pathol"},{"key":"9398_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/dc.23028","volume":"42","author":"S Asioli","year":"2014","unstructured":"Asioli S, Maletta F, Pagni F, Pacchioni D, Vanzati A, Mariani S, et al. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol. 2014;42:78\u201384.","journal-title":"Diagn Cytopathol"},{"key":"9398_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/thy.2013.0573","volume":"24","author":"CC Lubitz","year":"2014","unstructured":"Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid. 2014;24:958\u201365.","journal-title":"Thyroid"},{"key":"9398_CR11","first-page":"7988","volume":"8","author":"YS Lee","year":"2015","unstructured":"Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung CK. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol. 2015;8:7988\u201397.","journal-title":"Int J Clin Exp Pathol"},{"key":"9398_CR12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3892\/ol.2013.1227","volume":"5","author":"A Ieni","year":"2013","unstructured":"Ieni A, Barresi V, Branca G, Giuffr\u00e8 G, Rosa MA, Tuccari G. Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas. Oncol Lett. 2013;5:1536\u201340.","journal-title":"Oncol Lett"},{"key":"9398_CR13","first-page":"1267","volume":"7","author":"A Ieni","year":"2014","unstructured":"Ieni A, Barresi V, Caltabiano R, Cascone AM, Del Sordo R, Cabibi D, et al. Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation. Onco Targets Ther. 2014;7:1267\u201372.","journal-title":"Onco Targets Ther"},{"key":"9398_CR14","doi-asserted-by":"crossref","first-page":"22331","DOI":"10.3390\/ijms151222331","volume":"15","author":"A Ieni","year":"2014","unstructured":"Ieni A, Barresi V, Caltabiano R, Caleo A, Bonetti LR, Lanzafame S, et al. Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis. Int J Mol Sci. 2014;15:22331\u201341.","journal-title":"Int J Mol Sci"},{"key":"9398_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/apm.12483","volume":"124","author":"V Barresi","year":"2016","unstructured":"Barresi V, Ieni A, Cardia R, Licata L, Vitarelli E, Reggiani Bonetti L, et al. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. APMIS. 2016;124:188\u201393.","journal-title":"APMIS"},{"key":"9398_CR16","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1210\/jc.2003-032221","volume":"89","author":"G Salvatore","year":"2004","unstructured":"Salvatore G, Giannini R, Faviana P, Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET\/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:5175\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"9398_CR17","first-page":"660","volume":"6","author":"S Siriaunkgul","year":"1993","unstructured":"Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6:660\u20132.","journal-title":"Mod Pathol"},{"key":"9398_CR18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00000478-199412000-00005","volume":"18","author":"MB Amin","year":"1994","unstructured":"Amin MB, Ro JY, El-Sharkawy T, Lee KM, Troncoso P, Silva EG, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224\u201332.","journal-title":"Am J Surg Pathol"},{"key":"9398_CR19","first-page":"301","volume":"50","author":"V Barresi","year":"2006","unstructured":"Barresi V, Vitarelli E, Grosso M, Tuccari G, Barresi G. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren\u2019s histologic subtypes of gastric carcinomas. Eur J Histochem. 2006;50:301\u20139.","journal-title":"Eur J Histochem"},{"key":"9398_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1309\/AJCPFEA7KA0SBBNA","volume":"142","author":"V Barresi","year":"2014","unstructured":"Barresi V, Branca G, Vitarelli E, Tuccari G. Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am J Clin Pathol. 2014;142:375\u201383.","journal-title":"Am J Clin Pathol"},{"key":"9398_CR21","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.3748\/wjg.v21.i18.5548","volume":"21","author":"V Barresi","year":"2015","unstructured":"Barresi V, Branca G, Ieni A, Rigoli L, Tuccari G, Caruso RA. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas. World J Gastroenterol. 2015;21:5548\u201354.","journal-title":"World J Gastroenterol"},{"key":"9398_CR22","first-page":"149","volume":"9","author":"Y Cao","year":"2015","unstructured":"Cao Y, Zhu LZ, Jiang MJ, Yuan Y. Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review. Onco Targets Ther. 2015;9:149\u201358.","journal-title":"Onco Targets Ther"},{"key":"9398_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/ERC-15-0408","volume":"23","author":"SK Kim","year":"2016","unstructured":"Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, et al. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23:27\u201334.","journal-title":"Endocr Relat Cancer"},{"key":"9398_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10147-014-0754-7","volume":"20","author":"HY Kwak","year":"2015","unstructured":"Kwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, et al. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol. 2015;20:463\u201373.","journal-title":"Int J Clin Oncol"},{"key":"9398_CR25","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/thy.2013.0036","volume":"23","author":"JY Lim","year":"2013","unstructured":"Lim JY, Hong SW, Lee YS, Kim BW, Park CS, Chang HS, et al. Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center. Thyroid. 2013;23:1423\u201330.","journal-title":"Thyroid"},{"key":"9398_CR26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.12194","volume":"79","author":"V Marotta","year":"2013","unstructured":"Marotta V, Guerra A, Zatelli MC, Uberti ED, Di Stasi V, Faggiano A, et al. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto\u2019s thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf). 2013;79:733\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9398_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","volume":"19","author":"SK Kim","year":"2009","unstructured":"Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, et al. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid. 2009;19:137\u201341.","journal-title":"Thyroid"},{"key":"9398_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2008-1073155","volume":"40","author":"S Benvenga","year":"2008","unstructured":"Benvenga S. Update on thyroid cancer. Horm Metab Res. 2008;40:323\u20138.","journal-title":"Horm Metab Res"},{"key":"9398_CR29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1389202915999140404100958","volume":"15","author":"S Benvenga","year":"2014","unstructured":"Benvenga S, Koch CA. Molecular pathways associated with aggressiveness of papillary thyroid cancer. Curr Genomics. 2014;15:162\u201370.","journal-title":"Curr Genomics"},{"key":"9398_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12967-016-0958-x","volume":"14","author":"AK Murugan","year":"2016","unstructured":"Murugan AK, Qasem E, Al-Hindi H, Shi Y. Alzahrani AS Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer. J Transl Med. 2016;14:204.","journal-title":"J Transl Med"},{"key":"9398_CR31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00268-016-3534-x","volume":"40","author":"S Fraser","year":"2016","unstructured":"Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, et al. BRAF(V600E) mutation is associated with decreased disease-free survival in papillary thyroid cancer. World J Surg. 2016;40:1618\u201324.","journal-title":"World J Surg"},{"key":"9398_CR32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/thy.2015.0378","volume":"26","author":"P Aragon Han","year":"2016","unstructured":"Aragon Han P, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, et al. Association of BRAF(V600E) mutation and microrna expression with central lymph node metastases in papillary thyroid cancer: a prospective study from four endocrine surgery centers. Thyroid. 2016;26:532\u201342.","journal-title":"Thyroid"},{"key":"9398_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/ERC-14-0531","volume":"22","author":"F Li","year":"2015","unstructured":"Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis. Endocr Relat Cancer. 2015;22:159\u201368.","journal-title":"Endocr Relat Cancer"},{"key":"9398_CR34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11596-015-1476-4","volume":"35","author":"YJ Ma","year":"2015","unstructured":"Ma YJ, Deng XL, Li HQ. BRAF(V600E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2015;35:591\u20139.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"9398_CR35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/jc.2015-4031","volume":"101","author":"A Finkel","year":"2016","unstructured":"Finkel A, Liba L, Simon E, Bick T, Prinz E, Sabo E, et al. Sub-clonality for BRAF mutation in papillary thyroid carcinoma is associated with earlier disease stage. J Clin Endocrinol Metab. 2016;101:1407\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"9398_CR36","doi-asserted-by":"crossref","unstructured":"Lee DY, Hwang SM, An JH, Son KR, Baek SK, Kim SG et al. Predicting extrathyroidal extension in patients with papillary thyroid microcarcinoma according to a BRAF mutation. Clin Exp Otorhinolaryngol. 2016.","DOI":"10.21053\/ceo.2015.01655"},{"key":"9398_CR37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/thy.2015.0391","volume":"26","author":"Y Chen","year":"2016","unstructured":"Chen Y, Sadow PM, Suh H, Lee KE, Choi JY, Suh YJ, et al. BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid. 2016;26:248\u201355.","journal-title":"Thyroid"},{"issue":"12","key":"9398_CR38","first-page":"22525","volume":"8","author":"Y Sun","year":"2015","unstructured":"Sun Y, Shi C, Shi T, Yu J, Li Z. Correlation between the BRAF(v600E) gene mutation and factors influencing the prognosis of papillary thyroid microcarcinoma. Int J Clin Exp Med. 2015;8(12):22525\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"9398_CR39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-15-0254","volume":"173","author":"AU Bastos","year":"2015","unstructured":"Bastos AU, Oler G, Nozima BH, Moys\u00e9s RA, Cerutti JM. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma. Eur J Endocrinol. 2015;173:525\u201340.","journal-title":"Eur J Endocrinol"},{"key":"9398_CR40","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/modpathol.2015.92","volume":"28","author":"G Tallini","year":"2015","unstructured":"Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, et al. BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod Pathol. 2015;28:1343\u201359.","journal-title":"Mod Pathol"},{"key":"9398_CR41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","volume":"7","author":"EY Kim","year":"2009","unstructured":"Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2009;7:581\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9398_CR42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00405-011-1732-6","volume":"269","author":"YH Yoon","year":"2012","unstructured":"Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol. 2012;269:1013\u20137.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9398_CR43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/thy.2013.0126","volume":"23","author":"S Benvenga","year":"2013","unstructured":"Benvenga S. On the association between Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma: looking 100 years back, and hopefully, fewer years ahead to sort out this association. Thyroid. 2013;23:1180\u20131.","journal-title":"Thyroid"},{"key":"9398_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055450","volume":"8","author":"A Latina","year":"2013","unstructured":"Latina A, Gullo D, Trimarchi F, Benvenga S, Trimarchi F, Benvenga S. Hashimoto\u2019s thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS One. 2013;8, e55450.","journal-title":"PLoS One"},{"key":"9398_CR45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"JH Lee","year":"2013","unstructured":"Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168:343\u20139.","journal-title":"Eur J Endocrinol"},{"key":"9398_CR46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0194599812472426","volume":"148","author":"Y Lun","year":"2013","unstructured":"Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, et al. Hashimoto\u2019s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg. 2013;148:396\u2013402.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9398_CR47","doi-asserted-by":"crossref","unstructured":"Dobrinja C, Bernardi S, Fabris B, Eramo R, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. 2015; 2015:576576.","DOI":"10.1530\/endoabs.37.EP960"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-016-9398-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T20:52:04Z","timestamp":1718916724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-016-9398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9398"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9398-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}